miglustat dipharma
dipharma arzneimittel gmbh - miglustat - gaucher sygdom - andre fordøjelseskanaler og stofskifteprodukter - miglustat dipharma er angivet for den mundtlige behandling af voksne patienter med mild til moderat type 1 gaucher sygdom. miglustat dipharma kan kun anvendes i behandling af patienter, for hvem enzymsubstitutionsbehandlingen er uegnet. miglustat dipharma er indiceret til behandling af progressive neurologiske forstyrrelser hos voksne patienter, og pædiatriske patienter med niemann-picks sygdom type c.
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
phenmedipham flydende middel
forhandles af flere firmaer. - phenmedipham - flydende middel - 160 g/l phenmedipham
it-phenmedipham flydende middel
inter-trade a/s - phenmedipham - flydende middel - 157 g/l phenmedipham
it-phenmedipham 157 flydende middel
inter-trade agro a/s - phenmedipham - flydende middel - 157 g/l phenmedipham
it-phenmedipham ec pulver bejdse
inter-trade agro a/s - phenmedipham - pulver bejdse - 157 g/l phenmedipham
jbc phenmedipham flydende middel
nedab aps - phenmedipham - flydende middel - 167 g/l phenmedipham
nd phenmedipham se flydende middel
nedab aps - phenmedipham - flydende middel - 160 g/l phenmedipham
nitisinone "dipharma" 10 mg kapsler, hårde
dipharma arzneimittel gmbh - nitisinon - kapsler, hårde - 10 mg
nitisinone "dipharma" 5 mg kapsler, hårde
dipharma arzneimittel gmbh - nitisinon - kapsler, hårde - 5 mg